Clinical trial
Thyroxine Titration Study
NCT00111735 · Sir Charles Gairdner Hospital, Other · Unknown status
Key facts
| NCT number | NCT00111735 |
|---|---|
| Title | Thyroxine Titration Study |
| Official title | What is the Optimal Serum TSH Concentration During Thyroxine Treatment for Primary Hypothyroidism? Effects of Fine Titration of Thyroxine Dosage on Wellbeing, Quality of Life and Cognitive Function |
| Lead sponsor | Sir Charles Gairdner Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypothyroidism |
| Intervention type | Drug |
| Interventions | Thyroxine |
| Enrollment | 55 |
| Start date | Apr 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | May 25, 2005 |
| Last update posted | Jun 24, 2005 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: